The article references various studies on diabetes and cardiovascular health, focusing on topics like prevalence of type 1 and type 2 diabetes among children, guidelines for heart failure management, diabetes management in chronic kidney disease, effects of SGLT2 inhibitors on cardiovascular benefits, and impact of empagliflozin on left ventricular mass and function in patients with type 2 diabetes and coronary artery disease.